Riskpilot← Back to searchSign inGet full accessCleanForm Science AB
ABBankruptOrg 5592060601Research and experimental development on biotechnology · NACE 7211Est. 20190 employees
Revenue 2020
SEK 0
EBITDA margin
—
-173% vs 2019
Equity ratio
-28.5%
Financial strength
Net profit 2020
SEK -435K
-196% vs 2019
| Revenue | SEK 0 | — |
| EBITDA | SEK -391K | -173% |
| Net profit | SEK -435K | -196% |
| Total assets | SEK 813K | +197% |
| Equity | SEK -232K | -538% |
| Employees | 0 | — |
Legal name
CleanForm Science AB
Org number
5592060601
Legal form
Aktiebolag
NACE code
7211 · Research and experimental development on biotechnology
Founded
17 maj 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatornRegistrerad kvalificerad revisor saknas.
Company purpose
Bolaget ska bedriva forskning och utveckling inom bioteknikområdet samt produktion och global försäljning av produkter inom näringsområdet bioteknik och enzymteknik och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | — | — |
| EBITDA | −143 | −391 |
| Depreciation & amort. | −0 | −0 |
| EBIT | −143 | −391 |
| Net financials | −4 | −44 |
| Profit before tax | −147 | −435 |
| Tax | −0 | −0 |
| Net profit | −147 | −435 |
| Item | 2019 | 2020 |
|---|---|---|
| Total assets | 274 | 813 |
| Equity | 53 | −232 |
| Long-term debt | 188 | 964 |
| Short-term debt | 34 | 81 |
| Total debt | 222 | 1 045 |
EBITDA margin
-39100000.0%
This company
15.8%
Market median
-247468454% vs market
20192020
Equity ratio
-28.5%
This company
38.2%
Market median
-175% vs market
20192020
Return on equity
-43500000.0%
This company
18.4%
Market median
-236413143% vs market
20192020
Net profit margin
-43500000.0%
This company
8.1%
Market median
-537037137% vs market
20192020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192020
Debt / equity
4.50×
This company
0.62×
Market median
-626% vs market
20192020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-05-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AC Liquidator | Liquidator | 2022 | — | — |
HM Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CleanForm Science AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Christian Endsjö | Liquidator | 0 companies |
| Helén Marita Lyckstedt | Chief Auditor | 0 companies |
| Karl Ture Lennart Thern | Deputy Board Member | 0 companies |
| Bo Gösta Ohlström | Deputy Board Member | 0 companies |
| Bo Christer Hindrikes | Chairman | 0 companies |
| Britt-Marie Ohlström | Board of Directors | 0 companies |
| Erik Ingulf Magnus Tångring | Board of Directors | 0 companies |